title: Response of Burkholderia cenocepacia H111 to micro-oxia.
abstract: B. cenocepacia is an opportunistic human pathogen that is particularly problematic for patients suffering from cystic fibrosis (CF). In the CF lung bacteria grow to high densities within the viscous mucus that is limited in oxygen. Pseudomonas aeruginosa, the dominant pathogen in CF patients, is known to grow and survive under oxygen-limited to anaerobic conditions by using micro-oxic respiration, denitrification and fermentative pathways. In contrast, inspection of the genome sequences of available B. cenocepacia strains suggested that B. cenocepacia is an obligate aerobic and non-fermenting bacterium. In accordance with the bioinformatics analysis we observed that B. cenocepacia H111 is able to grow with as little as 0.1% O2 but not under strictly anoxic conditions. Phenotypic analyses revealed that H111 produced larger amounts of biofilm, pellicle and proteases under micro-oxic conditions (0.5%-5% O2, i.e. conditions that mimic those encountered in CF lung infection), and was more resistant to several antibiotics. RNA-Seq and shotgun proteomics analyses of cultures of B. cenocepacia H111 grown under micro-oxic and aerobic conditions showed up-regulation of genes involved in the synthesis of the exopolysaccharide (EPS) cepacian as well as several proteases, two isocitrate lyases and other genes potentially important for life in micro-oxia.
  
  
  METHODS
  RNA-Seq raw data files are accessible through the GEO Series accession number GSE48585. MS data have been deposited in the ProteomeXchange database (PXD000270).
authors.affiliation: Department of Microbiology, University of Zurich, Zürich, Switzerland.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Pessi
authors.forename: Rubina
authors.initials: R
authors.lastname: Braunwalder
authors.forename: Alexander
authors.initials: A
authors.lastname: Grunau
authors.forename: Ulrich
authors.initials: U
authors.lastname: Omasits
authors.forename: Christian H
authors.initials: CH
authors.lastname: Ahrens
authors.forename: Leo
authors.initials: L
authors.lastname: Eberl
mesh_terms: D018441:Biofilms / Q000254:growth & development; D057508:Burkholderia cenocepacia / Q000235:genetics / Q000378:metabolism* / Q000502:physiology*; D019295:Computational Biology; D015964:Gene Expression Regulation, Bacterial / Q000235:genetics / Q000502:physiology; D010100:Oxygen / Q000378:metabolism*; D011135:Polysaccharides, Bacterial / Q000378:metabolism; D040901:Proteomics
chemical_list: D011135:Polysaccharides, Bacterial; D010100:Oxygen
references.citation: Microbiology (Reading). 2001 Sep;147(Pt 9):2517-2528
references.pmid: 11535791
references.citation: Mol Microbiol. 2007 Jul;65(1):153-65
references.pmid: 17581126
references.citation: Nat Biotechnol. 2012 Oct;30(10):918-20
references.pmid: 23051804
references.citation: Curr Microbiol. 2007 Jun;54(6):440-4
references.pmid: 17457645
references.citation: Infect Immun. 1990 May;58(5):1344-9
references.pmid: 2139011
references.citation: Arch Microbiol. 2004 Feb;181(2):89-96
references.pmid: 14714103
references.citation: Clin Microbiol Infect. 2010 Jul;16(7):821-30
references.pmid: 20880411
references.citation: PLoS Pathog. 2011 Oct;7(10):e1002287
references.pmid: 21998585
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Biochem Soc Trans. 2002 Aug;30(4):653-8
references.pmid: 12196157
references.citation: Nat Methods. 2007 Mar;4(3):207-14
references.pmid: 17327847
references.citation: PLoS One. 2013;8(3):e58943
references.pmid: 23516582
references.citation: Mol Microbiol. 2004 Feb;51(4):1193-203
references.pmid: 14763990
references.citation: Nat Genet. 2011 Nov 13;43(12):1275-80
references.pmid: 22081229
references.citation: Appl Environ Microbiol. 2010 Jan;76(2):441-50
references.pmid: 19948863
references.citation: Microbiology (Reading). 2002 Oct;148(Pt 10):3195-3202
references.pmid: 12368453
references.citation: Mol Plant Microbe Interact. 2007 Nov;20(11):1353-63
references.pmid: 17977147
references.citation: Nat Biotechnol. 2010 Jul;28(7):647-50
references.pmid: 20622826
references.citation: Int J Mol Med. 2013 Feb;31(2):437-46
references.pmid: 23232950
references.citation: Mol Microbiol. 1991 Jun;5(6):1469-81
references.pmid: 1787797
references.citation: Microbiol Mol Biol Rev. 1997 Dec;61(4):533-616
references.pmid: 9409151
references.citation: Environ Microbiol. 2011 Jul;13(7):1682-9
references.pmid: 21429065
references.citation: J Infect Dis. 1994 Dec;170(6):1616-21
references.pmid: 7996008
references.citation: Res Microbiol. 1997 Jan;148(1):37-43
references.pmid: 9404503
references.citation: Nat Rev Microbiol. 2005 Feb;3(2):144-56
references.pmid: 15643431
references.citation: J Bacteriol. 2004 Jul;186(14):4596-604
references.pmid: 15231792
references.citation: PLoS Biol. 2009 Mar 3;7(3):e48
references.pmid: 19260763
references.citation: Genome Biol. 2010;11(10):R106
references.pmid: 20979621
references.citation: Appl Environ Microbiol. 2005 Nov;71(11):6998-7007
references.pmid: 16269735
references.citation: Anal Biochem. 1987 Jan;160(1):47-56
references.pmid: 2952030
references.citation: Int J Med Microbiol. 2010 Dec;300(8):549-56
references.pmid: 20951638
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3976-81
references.pmid: 19234113
references.citation: Southeast Asian J Trop Med Public Health. 1996 Mar;27(1):111-8
references.pmid: 9031412
references.citation: J Clin Invest. 2002 Feb;109(3):317-25
references.pmid: 11827991
references.citation: Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43
references.pmid: 12458153
references.citation: Dev Cell. 2002 Oct;3(4):593-603
references.pmid: 12408810
references.citation: J Cyst Fibros. 2007 Apr;6(2):145-52
references.pmid: 16860003
references.citation: Proteomics. 2010 Apr;10(7):1391-400
references.pmid: 20104621
references.citation: Nat Rev Microbiol. 2008 Mar;6(3):199-210
references.pmid: 18264116
references.citation: Mol Cell Proteomics. 2004 Oct;3(10):1023-38
references.pmid: 15284337
references.citation: J Bacteriol. 1984 Dec;160(3):928-34
references.pmid: 6438064
references.citation: FEMS Microbiol Lett. 2000 Mar 15;184(2):273-8
references.pmid: 10713433
references.citation: BMC Microbiol. 2010 Nov 30;10:303
references.pmid: 21114871
references.citation: Microbiologyopen. 2012 Jun;1(2):225-42
references.pmid: 22950027
references.citation: Lancet. 1990 Nov 3;336(8723):1094-6
references.pmid: 1977981
references.citation: PLoS One. 2012;7(11):e49966
references.pmid: 23185499
references.citation: Mol Microbiol. 2011 Oct;82(2):327-41
references.pmid: 21883527
references.citation: EMBO J. 1985 Apr;4(4):891-8
references.pmid: 2990912
references.citation: J Bacteriol. 1991 Mar;173(5):1598-606
references.pmid: 1900277
references.citation: J Clin Microbiol. 2009 Dec;47(12):4084-9
references.pmid: 19812273
references.citation: FEMS Microbiol Rev. 2011 Jan;35(1):124-46
references.pmid: 20584083
references.citation: Front Microbiol. 2011 May 05;2:103
references.pmid: 21833336
references.citation: Mol Microbiol. 2012 Jan;83(2):362-78
references.pmid: 22171913
references.citation: Nucleic Acids Res. 2012 Jan;40(Database issue):D284-9
references.pmid: 22096231
references.citation: Am J Respir Crit Care Med. 2008 May 1;177(9):995-1001
references.pmid: 18263800
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6554-9
references.pmid: 23576728
references.citation: J Appl Microbiol. 2008 Jun;104(6):1539-51
references.pmid: 18217926
references.citation: J Gen Microbiol. 1993 Mar;139(3):441-5
references.pmid: 8386219
references.citation: ISME J. 2013 Aug;7(8):1568-81
references.pmid: 23486248
references.citation: Syst Appl Microbiol. 2001 Apr;24(1):1-14
references.pmid: 11403388
references.citation: J Gen Microbiol. 1984 Aug;130(8):2015-22
references.pmid: 6432955
references.citation: Appl Environ Microbiol. 1998 Oct;64(10):4035-9
references.pmid: 9758837